abstract |
The present application discloses a compound having inhibitory activity against LRRK2. The application also discloses a pharmaceutical composition comprising the compound and a method of using the compound to treat diseases and disorders, including neurodegenerative diseases and disorders, such as Parkinson's disease and brain cancer (eg, gliomas and glioblastomas). |